V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195466 | 20152261 | 1.54 | 79.8 | Palliative (P) | null | 2021-12-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101694548 |
| 20195475 | 20152262 | 0 | 67.9 | Palliative (P) | 2019-06-15 | 2019-06-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100383294 |
| 20195476 | 20152263 | 1.63 | 116.8 | Adjuvant (A) | 2018-01-16 | 2018-02-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100500654 |
| 20195479 | 20152264 | 1.76 | 79 | null | 2019-08-22 | 2019-09-01 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100008514 |
| 20195486 | 20152265 | 1.58 | 59.1 | null | null | 2016-09-12 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101008089 |
| 20195504 | 20152266 | 1.61 | 72 | Neo-adjuvant (N) | 2020-06-09 | 2020-06-14 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 101568889 |
| 20195507 | 20152267 | 1.84 | 59 | Palliative (P) | 2017-07-10 | 2017-07-12 | Docetaxel | 02 | N | DOCETAXEL | 100193126 |
| 20195515 | 20152268 | 1.76 | 65 | Palliative (P) | 2021-03-21 | 2021-04-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100564187 |
| 20195516 | 20152269 | 1.61 | 82 | null | 2017-10-12 | 2017-10-30 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 101743268 |
| 20195520 | 20152270 | 1.59 | 58.5 | null | null | 2017-03-31 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 101867162 |
| 20195523 | 20152271 | 1.9 | 50.3 | null | 2017-04-18 | 2017-04-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101013565 |
| 20195532 | 20152272 | 1.7 | 57.6 | Palliative (P) | 2018-08-10 | 2018-09-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100870356 |
| 20195535 | 20152273 | 1.63 | 69.1 | Adjuvant (A) | 2016-08-20 | 2016-08-26 | Docetaxel | 02 | N | DOCETAXEL | 100606234 |
| 20195546 | 20152274 | 1.76 | 72.5 | null | 2018-04-19 | 2018-04-23 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101741425 |
| 20195547 | 20152275 | 1.58 | 56.7 | Palliative (P) | 2018-09-17 | 2018-09-17 | Docetaxel | 02 | N | DOCETAXEL | 101448244 |
| 20195553 | 20152276 | null | 105.6 | Palliative (P) | 2016-08-13 | 2016-08-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100804314 |
| 20195556 | 20152277 | 1.57 | 71.8 | Palliative (P) | 2019-03-22 | 2019-04-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101285432 |
| 20195557 | 20152278 | 1.58 | 57.5 | Palliative (P) | 2019-09-25 | 2019-09-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100492201 |
| 20195564 | 20152279 | 1.75 | 75 | 03 | 2018-08-09 | 2018-08-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100651874 |
| 20195566 | 20152280 | 1.83 | 76.5 | Palliative (P) | 2016-10-08 | 2016-10-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100661580 |
| 20195570 | 20152281 | 1.85 | 108.5 | Palliative (P) | 2018-01-07 | 2018-01-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100683810 |
| 20195572 | 20152282 | 1.53 | 68 | Palliative (P) | 2019-05-22 | 2019-06-05 | Docetaxel | 02 | N | DOCETAXEL | 100075171 |
| 20195573 | 20152283 | 1.47 | 71.55 | Palliative (P) | 2016-07-20 | 2016-07-24 | Docetaxel | 02 | N | DOCETAXEL | 101681600 |
| 20195575 | 20152284 | 1.59 | 73.9 | Disease modification (D) | 2019-05-24 | 2019-06-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100014831 |
| 20195591 | 20152285 | 1.76 | 74.8 | Palliative (P) | 2017-03-10 | 2017-03-15 | Docetaxel | 02 | N | DOCETAXEL | 100544120 |
| 20195593 | 20152286 | 1.74 | 50.3 | Palliative (P) | 2021-07-05 | 2021-07-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100137249 |
| 20195595 | 20152287 | 1.7 | 50 | null | 2018-03-12 | 2018-07-05 | Docetaxel | 02 | null | DOCETAXEL | 101781685 |
| 20195601 | 20152288 | 1.53 | 99.6 | Palliative (P) | 2016-05-30 | 2016-06-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101737317 |
| 20195603 | 20152289 | 1.7 | 57.5 | Curative (C) | 2016-11-14 | 2018-12-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100673914 |
| 20195605 | 20152290 | 1.55 | 78.7 | Palliative (P) | 2020-11-28 | 2020-12-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101794216 |
| 20195614 | 20152291 | 1.77 | 58.2 | null | 2020-06-14 | 2020-06-21 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 101680082 |
| 20195616 | 20152292 | null | 83.9 | Adjuvant (A) | 2018-01-03 | 2018-02-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100178643 |
| 20195623 | 20152293 | 1.78 | 84.2 | Palliative (P) | 2019-10-13 | 2020-04-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100191321 |
| 20195626 | 20152294 | 1.59 | 49.8 | null | 2016-11-23 | 2016-12-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101711587 |
| 20195629 | 20152295 | 1.69 | 70.3 | null | 2016-08-27 | 2016-09-14 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101525021 |
| 20195634 | 20152296 | 1.83 | 68 | Palliative (P) | 2021-03-01 | 2021-03-21 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100713407 |
| 20195640 | 20152297 | 1.81 | 94.4 | Curative (C) | 2019-01-12 | 2019-01-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100028895 |
| 20195644 | 20152298 | null | 82.8 | Palliative (P) | 2017-01-24 | 2017-01-24 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101010173 |
| 20195645 | 20152299 | 1.55 | 58.2 | Curative (C) | 2019-05-11 | 2019-05-16 | Docetaxel | 02 | N | DOCETAXEL | 100741823 |
| 20195647 | 20152300 | 1.66 | 69 | Palliative (P) | 2018-08-21 | 2018-09-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101383999 |
| 20195648 | 20152301 | 1.71 | 79.1 | Palliative (P) | 2019-11-08 | 2019-11-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101506317 |
| 20195649 | 20152302 | 1.5 | 74.6 | Palliative (P) | 2017-12-23 | 2018-04-02 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100575086 |
| 20195656 | 20152303 | 1.66 | 58 | Palliative (P) | 2016-02-27 | 2016-03-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100383244 |
| 20195661 | 20152304 | 1.58 | 59.1 | 03 | null | 2019-02-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101392234 |
| 20195663 | 20152305 | 1.83 | 107.3 | Palliative (P) | 2017-10-12 | 2017-10-22 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100522660 |
| 20195670 | 20152306 | 1.69 | 43.6 | null | 2016-08-12 | 2016-12-21 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100143079 |
| 20195671 | 20152307 | 1.74 | 50.95 | null | 2018-04-06 | 2018-04-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100676871 |
| 20195680 | 20152308 | null | 109.2 | Palliative (P) | 2018-06-21 | 2018-07-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100967817 |
| 20195681 | 20152309 | 1.83 | 85 | Palliative (P) | 2017-10-24 | 2017-11-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100895369 |
| 20195683 | 20152310 | 1.76 | 72.1 | Palliative (P) | 2017-08-09 | 2017-08-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100675170 |